Cytosorbents ROA 2007-2020 | CTSO

Current and historical return on assets (ROA) values for Cytosorbents (CTSO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Cytosorbents ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $-0.02B $0.05B -45.64%
2020-03-31 $-0.02B $0.04B -56.25%
2019-12-31 $-0.02B $0.03B -69.57%
2019-09-30 $-0.02B $0.03B -68.85%
2019-06-30 $-0.02B $0.03B -53.54%
2019-03-31 $-0.02B $0.03B -56.72%
2018-12-31 $-0.02B $0.03B -51.91%
2018-09-30 $-0.02B $0.03B -49.59%
2018-06-30 $-0.01B $0.04B -51.38%
2018-03-31 $-0.01B $0.03B -41.67%
2017-12-31 $-0.01B $0.02B -47.37%
2017-09-30 $-0.01B $0.02B -70.97%
2017-06-30 $-0.01B $0.02B -86.27%
2017-03-31 $-0.01B $0.01B -114.29%
2016-12-31 $-0.01B $0.01B -109.09%
2016-09-30 $-0.01B $0.01B -88.89%
2016-06-30 $-0.01B $0.01B -93.62%
2016-03-31 $-0.01B $0.01B -58.33%
2015-12-31 $-0.01B $0.01B -74.07%
2015-09-30 $-0.02B $0.01B -133.33%
2015-06-30 $-0.02B $0.01B -141.67%
2015-03-31 $-0.02B $0.02B -186.67%
2014-12-31 $-0.02B $0.01B -175.61%
2014-09-30 $-0.01B $0.01B -97.30%
2014-06-30 $-0.01B $0.01B -90.32%
2014-03-31 $-0.01B $0.01B -104.35%
2013-12-31 $-0.01B $0.00B -171.43%
2013-09-30 $-0.01B $0.00B -184.62%
2013-06-30 $-0.01B $0.00B -200.00%
2013-03-31 $-0.01B $0.00B -200.00%
2012-12-31 $-0.01B $0.00B -200.00%
2012-09-30 $-0.01B $0.00B -218.18%
2012-06-30 $-0.01B $0.00B -254.55%
2012-03-31 $-0.01B $0.00B -233.33%
2011-12-31 $-0.01B $0.00B -233.33%
2011-09-30 $-0.01B $0.00B -200.00%
2011-06-30 $-0.01B $0.00B -200.00%
2011-03-31 $-0.00B $0.00B -228.57%
2010-12-31 $-0.00B $0.00B -200.00%
2010-09-30 $-0.00B $0.00B -200.00%
2010-06-30 $-0.00B $0.00B -200.00%
2010-03-31 $-0.00B $0.00B -171.43%
2009-12-31 $-0.00B $0.00B -150.00%
2009-09-30 $-0.00B $0.00B -177.78%
2009-06-30 $-0.00B $0.00B -133.33%
2009-03-31 $-0.00B $0.00B -114.29%
2008-12-31 $-0.00B $0.00B -133.33%
2008-09-30 $-0.00B $0.00B -160.00%
2008-06-30 $-0.00B $0.00B -228.57%
2008-03-31 $-0.00B $0.00B -320.00%
2007-12-31 $-0.00B $0.00B -228.57%
2007-06-30 $-0.00B $0.00B -100.00%
2007-03-31 $-0.01B $0.00B -175.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.374B $0.025B
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $189.199B 35.50
Medtronic (MDT) Ireland $144.638B 27.24
Stryker (SYK) United States $77.357B 30.00
Boston Scientific (BSX) United States $55.052B 31.80
Lonza Group Ag (LZAGY) Switzerland $46.603B 0.00
Baxter (BAX) United States $42.002B 0.00
Terumo (TRUMY) Japan $30.472B 38.95
EssilorLuxottica Societe Anonyme (ESLOY) France $29.029B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.753B 23.86
ResMed (RMD) United States $24.635B 35.72
Smith & Nephew SNATS (SNN) United Kingdom $17.211B 0.00
Sunny Optical Technology (SNPTF) China $17.067B 0.00
Bio-Rad Laboratories (BIO) United States $15.239B 68.92
Insulet (PODD) United States $14.773B 625.06
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $7.942B 42.07
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.424B 11.02
Canopy Growth (CGC) Canada $6.075B 0.00
Hill-Rom Holdings (HRC) United States $5.499B 13.65
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.571B 0.00
Haemonetics (HAE) United States $4.202B 28.00
ICU Medical (ICUI) United States $4.157B 31.71
Neogen (NEOG) United States $4.000B 66.75
Envista Holdings (NVST) United States $3.888B 26.51
Abcam (ABCZY) $3.404B 0.00
TG Therapeutics (TGTX) United States $3.312B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.110B 0.00
National Vision Holdings (EYE) United States $3.084B 479.38
Agios Pharmaceuticals (AGIO) United States $2.658B 0.00
NuVasive (NUVA) United States $2.541B 35.41
DFB Healthcare Acquisitions (AHCO) United States $1.908B 0.00
AtriCure (ATRC) United States $1.797B 0.00
NanoString Technologies (NSTG) United States $1.748B 0.00
MacroGenics (MGNX) United States $1.710B 0.00
Cardiovascular Systems (CSII) United States $1.422B 0.00
Aphria (APHA) Canada $1.349B 0.00
InMode (INMD) Israel $1.158B 29.21
Cerus (CERS) United States $1.052B 0.00
Quanterix (QTRX) United States $0.964B 0.00
Owens & Minor (OMI) United States $0.915B 20.49
OraSure Technologies (OSUR) United States $0.900B 0.00
PetIQ (PETQ) United States $0.883B 25.34
BioLife Solutions (BLFS) United States $0.871B 453.50
Lantheus Holdings (LNTH) United States $0.863B 11.96
Aurora Cannabis (ACB) Canada $0.754B 0.00
Phibro Animal Health (PAHC) United States $0.727B 16.63
Vapotherm (VAPO) United States $0.725B 0.00
Meridian Bioscience (VIVO) United States $0.714B 16.49
Omeros (OMER) United States $0.671B 0.00
LeMaitre Vascular (LMAT) United States $0.667B 40.69
Zynex (ZYXI) United States $0.597B 52.12
Eagle Pharmaceuticals (EGRX) United States $0.542B 76.60
Surmodics (SRDX) United States $0.537B 58.94
VAREX IMAGING (VREX) United States $0.486B 21.07
HEXO (HEXO) $0.374B 0.00
Viemed Healthcare (VMD) United States $0.368B 13.15
Utah Medical Products (UTMD) United States $0.297B 25.49
Surface Oncology (SURF) United States $0.289B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.280B 0.00
Organigram Holdings (OGI) Canada $0.222B 0.00
Female Health (VERU) United States $0.201B 0.00
Chimerix (CMRX) United States $0.177B 0.00
Wound Management Technologies (SMTI) United States $0.172B 0.00
Bovie Medical (APYX) United States $0.169B 0.00
Fonar (FONR) United States $0.163B 14.48
Exagen (XGN) United States $0.161B 0.00
Liberty Health Sciences (LHSIF) Canada $0.135B 0.00
Evolus (EOLS) United States $0.131B 0.00
Capricor Therapeutics (CAPR) United States $0.110B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.098B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Rockwell Medical (RMTI) United States $0.090B 0.00
United-Guardian (UG) United States $0.070B 15.64
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
MTech Acquisition (KERN) United States $0.059B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 10.64
Nephros (NEPH) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
FSD PHARMA INC (HUGE) Canada $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
NF Energy Saving (BIMI) China $0.018B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00